A brand of hair growth products sold nationwide through Amazon was recalled over the risk of poisoning attributed to a lack of child-resistant packaging, federal officials said.
“The hair serum contains minoxidil, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act,” the agency said, referring to the 1970 law that requires hazardous household products to use such packaging. “The hair serum’s packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.”
No injuries have been reported in connection with the product, which was manufactured in China and sold by Japan-based DrHealBeauty from June 2025 through August 2025 for around $24 dollars. Around 6,200 products are under recall, said the CPSC.
The kits have two black spray bottles and labels with the text “Tuymec Minoxidil Hair Growth,” “Advanced Formula,” and “5% Minoxidil with BIOTIN,” in black cartons with white and silver lettering, the agency said.
The product packaging also has the text “Drug Facts” on the back as well as information about its distributor on one side, along with icons making claims about the product, its batch, expiration dates, and manufacturing on the bottom, according to the agency.
“Consumers should secure the recalled serum bottles out of sight and reach of children immediately and contact DrHealBeauty for a free empty replacement bottle with a child-resistant closure into which consumers should transfer the recalled bottle’s contents,” the CPSC said.
Minoxidil, sometimes sold under the brand name Rogaine or Loniten, is approved by the Food and Drug Administration (FDA) to treat hair loss and also for high blood pressure.
According to the Mayo Clinic’s website, the usage of too much minoxidil can cause rapid heartbeat, dizziness, chest pain, swelling of hands or feet, rapid weight gain, and unwanted hair growth elsewhere. It can also lead to severe scalp irritation, itching, and dizziness or fatigue.
A study published on the National Library of Medicine’s website last year said that overall, at least “14 patients have been reported to have developed systemic side effects following an overdose of minoxidil-containing medications.” The study further noted that all the patients who overdosed had experienced hypotension, or low blood pressure, or tachycardia, which is an abnormally fast resting heart rate of more than 100 beats per minute.
None of the patients listed in the study died, although one suffered a heart attack, it said.
At the time, the acting head of the CPSC, Peter Feldman, attributed a surge of recalled product warnings to Chinese companies selling products in the United States.
